Poor Company Focused on Disenfranchising Sales
Pros
> There are very limited pockets of high-profile surgeons using the technology, and if one is fortunate enough to have a surgeon that is familiar with a higher-profile surgeon user, you could garner a conversion of that target surgeons' practice. > You'll have a job. > You'll have medical. > If you can live off a minimum Sales wage with an insignificant bag consisting of a uni knee and total knee, you can be content.
Cons
> This is 'not' a sales-centric company in the least, as it is driven by the CFO chipping-away at Sales income to show greater revenue growth every couple years. Sales Management support of Territory Sales Reps is lackluster at best. > 3 downward comp plan cuts over 6 years, which significantly erode a Sales Persons' income, and which disenfranchise Sales-Person growth financially, without new products to maintain sales upward momentum. > Their Manufacturing lead-times have increased 50% from 4-weeks to 6-weeks over the last 2 years, making it difficult for Surgeons to consider the technology for many patients, and leads to more lost Sales income. > With essentially one product for 4 years, a standard primary total knee system with limited indications, and which there is zero back-up intra-operatively for, and which there is zero room for intra-operative surgical error for, the actual market is extremely limited. Many surgeons see Conformis' technology as a liability to adopt against the backdrop of rich clinical history and experience with off-the-shelf implants, for which they have intra-operative flexibility with. > Sales, Marketing and Engineering Management do not take Sales Rep's input on the technologies instrument system improvement seriously, which has many reps using some competitive instruments to address their iTotal Systems' instrument short-falls. > The sale is purely concept, as Conformis' surgeon testimonials and limited clinicals make for a positive 'opinion' about outcomes and value instead of significantly proven value proposition that has depth of substance for encourage a surgeon to adopt. > Their Manufacturing lead-times have increased 50% from 4-weeks to 6-weeks, making it difficult for Surgeons to consider the technology for many patients, and leads to more lost Sales income. > Their Marketing team doesn't know how to Sell or position products clearly compared to competition, and overall have very limited Total Joint Orthopedic experience, compounding their inability to support Sales.
